Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001389490 | SCV001590882 | pathogenic | Sphingolipid activator protein 1 deficiency | 2021-02-19 | criteria provided, single submitter | clinical testing | Disruption of the initiator codon has been demonstrated to severely reduce the expression of the PSAP protein in cell culture and patient cells (PMID: 20484222). For these reasons, this variant has been classified as Pathogenic. Disruption of the initiator codon has been observed in individual(s) with saposin C deficiency (PMID: 17616409, 20484222, 1371116). This variant is not present in population databases (ExAC no frequency). This sequence change affects the initiator methionine of the PSAP mRNA. The next in-frame methionine is located at codon 76. |